Pretreatment insight as a predictor of alliance strengthening in supportive vs. supportive-expressive treatment

Figures & data

Table I. Patient demographic and clinical characteristics as a function of treatment condition.

Patient characteristics	Total sample (N = 55)	ST (N = 27)	SET (N = 28)	Statistical test	p Value
Demographic variables
Age, years, M (SD)	29.6 (6.7)	30.8 (5.8)	28.5 (7.4)	t(53) = 1.28	.21
Female	56.4 (31)	59.3 (16)	53.6 (15)	χ^2(1) = .18	.79
Income > average	21.8 (12)	14.8 (4)	28.6 (8)	χ^2(1) = 1.73	.33
Education, years, M (SD)	13.8 (2.4)	13.9 (2.7)	13.6 (2.1)	t(53) = 0.6	.55
Employed	69.1 (38)	74.1 (20)	64.3 (18)	χ^2(1) = 1.03	.38
Married	12.7 (7)	18.5 (5)	7.1 (2)	χ^2(1) = 1.6	.25
Jewish	72.7 (40)	77.8 (21)	67.9 (19)	χ^2(1) = .68	.55
Clinical variables
Current medication	14.5 (8)	18.5 (5)	10.7 (3)	χ^2(1) = .67	.47
Previous medication	18.2 (10)	18.5 (5)	17.9 (5)	χ^2(1) = .02	1
Previous psychotherapy	41.8 (23)	44.4 (12)	39.3 (11)	χ^2(1) = .26	.78
Comorbidity with personality disorder	76.4 (42)	74.1 (20)	78.6 (22)	χ^2(1) = .15	.76
Drop-outs	3.6 (2)	3.7 (1)	3.6 (1)	χ^2(1) = .001	1
Remote treatment, yes	23.6 (13)	25.9 (7)	21.4 (6)	χ^2(1) = .15	.76

Note. Values shown as % (n) unless otherwise noted. ST = supportive treatment; SET = supportive-expressive treatment.

Figure 1. The 3-way interaction between pretreatment insight, treatment condition and time in predicting alliance strengthening. Note. The X axis refers to time operationalized as log of time according to the model. The Y axis refers to strengthening of the alliance (WAI) from one session to the next throughout treatment. The Solid line refers to patients with a high level (average+SD) of pretreatment insight (SUIP-I); the Dashed line refers to patients with an average level of pretreatment insight; and the Dotted line refers to patients with a low level (average–SD) of pretreatment insight. ST = supportive-treatment, SET = supportive-expressive treatment.